Cargando…
Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal
Cancer stem cells possess the capacity for self-renewal and resistance to chemotherapy. It is therefore crucial to understand the molecular regulators of stemness in the quest to develop effective cancer therapies. TAZ is a transcription activator that promotes stem cell functions in post-developmen...
Autores principales: | Chai, Tin Fan, Manu, Kanjoormana Aryan, Casey, Patrick J., Wang, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391290/ https://www.ncbi.nlm.nih.gov/pubmed/32561852 http://dx.doi.org/10.1038/s41388-020-1364-7 |
Ejemplares similares
-
Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair
por: Tang, Jingyi, et al.
Publicado: (2021) -
Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt)
por: Baron, Rudi A, et al.
Publicado: (2004) -
Isoprenylcysteine Carboxylmethyltransferase-Based
Therapy for Hutchinson–Gilford Progeria Syndrome
por: Marcos-Ramiro, Beatriz, et al.
Publicado: (2021) -
Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms
por: Lau, H Y, et al.
Publicado: (2017) -
Lidocaine exerts anticancer activity in bladder cancer by targeting isoprenylcysteine carboxylmethyltransferase (ICMT)
por: Teng, Xiaodan, et al.
Publicado: (2021)